Press-release for stocks related to authorized for NVAX

Prices are updated after-hours

Novavax's Updated COVID-19 Vaccine Now Authorized in Canada
Published: 2023-12-05 (Crawled : 21:00) - prnewswire.com
NVAX | $4.285 5.28% 1.6M

| -27.19% | O: 0.18% H: 3.93% C: -0.36%
covid-19 authorized vaccine canada

Novavax Nuvaxovid™ COVID-19 Vaccine▼ Authorized in the United Kingdom for Use as a Booster in Adults
Published: 2022-11-09 (Crawled : 15:20) - biospace.com/
NVAX | $4.285 5.28% 1.6M

| -79.29% | O: 0.15% H: 11.69% C: -5.34%
covid-19 authorized

| -92.88% | O: -0.68% H: 13.79% C: 13.27%
covid-19 authorized vaccine

| -98.28% | O: -15.33% H: 1.39% C: -5.06%
covid india vaccine merge submission authorized emergency use authorization

Novavax Announces Start of Rolling Review by Multiple Regulatory Authorities for COVID-19 Vaccine Authorization
Published: 2021-02-04 (Crawled : 22:01) - globenewswire.com
NVAX | $4.285 5.28% 1.6M

| -98.55% | O: 0.96% H: 5.78% C: 2.31%
covid vaccine authorized covid-19

88%

12%

MTTR | News M | $4.595 164.08% 13M

AGBA | $2.355 88.4% 34M

EDBL | News | $6.75 79.52% 1.5M

CZOO | $8.77 75.75% 11M

MTC | $2.28 46.15% 2.6M

VNRX | $0.84 40.0% 2.6M

OPRT | News | $3.14 39.56% 7.6M

MLEC | $1.865 33.21% 2.4M

PALI | $6.37 29.21% 21M

CMAX | $4.12 28.35% 65K

Save your searches and get alerts when important news are released.